A simple high-performance liquid chromatographic practical approach for determination of flurbiprofen

Journal of Advanced Pharmaceutical Technology and Research

Volumn 2, Issue 3, 2011, Pages 151-155

  Akhlaq, Muhammad ^a,b   Khan, Gul Majid ^a   Wahab, Abdul ^a   Khan, Arshad ^a   Hussain, Abid ^a   Nawaz, Asif ^a   Abdelkader, Hamdy ^b,c  

^a GOMAL UNIVERSITY   (Pakistan)

^b UNIVERSITY OF AUCKLAND   (New Zealand)

^c Minia University   (Egypt)

Author keywords

Chromatography; flurbiprofen; isocratic; quality control; validation

Indexed keywords

EID: 85174353455     PISSN: 22314040     EISSN: 09762094     Source Type: Journal    
DOI: 10.4103/2231-4040.85529     Document Type: Article

References (16)

1. Brooks PM, Day RD. Nornal anti-inflammatory drugs: Differences and similarities. N Eng J Med 1991;324:1716-25.
2. Sud RN. Greval RS, Bajwa RS. Topical flurbiprofen therapy in vernal keratoconjunctivitis. Indian J Med Sci 1995;49:205-9.
3. Sajeev C, Ranendra NS. Simple rapid validated RP-LC method for the estimation of flurbiprofen in rabbit serum and Aqueous Humor. Analyt Lett 2008;41:1318-34.
4. Josheph C. The role of NSAIDs in the management of postoperative ophthalmic inflammation. Drugs 2007;67:1291-308.
5. Juchelková J, Hofer M, Pospísil M, Pipalová I. Radioprotective effects of flurbiprofen and its nitroderivative. Physiol Res. 1998;47:73-80.
6. Galasko DR, Graff-Radford N, May S, Hendrix S, Cottrell BA, Sagi SA, et al. Safety, tolerability, pharmacokinetics, and Abeta levels after short-term administration of R-flurbiprofen in healthy elderly individuals. Alzheimer Dis Assoc Disord 2007; 21:292-9.
7. Monograph on flurbiprofen, in United States Pharmacopoeia (USP). Rockville MD. Editor. United States Pharmacopoeia Convention. 2000; p. 748-50.
8. British Pharmacopoeia. British Pharmacop-oeia Commission. 2008; p. 612-13.
9. Nagwa H, Fodaa O, Al Goharya A. High Performance liquid chromatographic determination of flurbiprofen in pharmaceutical dosage forms analyt Lett 1994;27:2523-34.
10. Szpunar GJ, Albert KS, Bole GG, Dreyfus JN, Lockwood GF, Wagner JG, et al. Pharmacokinetics of flurbiprofen in man. I. Area/ dose relationships. Biopharm Drug Dispos 1987;8:273-83.
11. GeisslingerG, Menzel-SoglowekS, SchusterO, BruneK.Stereoselective high-performance liquid chromatographic determination of flurbiprofen in human plasma. J Chromatogr 1992;573:163-67.
12. Shah VP, Midha KK, Dighe S, McGilveray IJ, Skelly JP, Yacobi A, et al. Analytical methods validation: Bioavailability, bioequivalence, and pharmacokinetic studies. Int J Pharm 1992;82:1-7.
13. Krull I, Szulc M. Detection sensitivity and selectivity, Practical HPLC method development in: Snyder LR, Kirkland JJ, Glajch JL. Editors. Canada. John Wile and Sons, Inc; 1997.
14. Sinha VR, Monika, Trehan A, Kumar M, Singh S, Bhinge JR. Stress studies on acyclovir. J Chromatogr Sci 2007;45:319-24.
15. ICH, Guidance for industry: Q2B validation for analytical procedures: methodology. In: U.S. Department of Health and Human Services Food and Drug Administration editors. Administration. USA: Center for Evaluation and Research; 1996.
16. Wiberg K, Andersson M, Hagman A, Jacobsson SP. Peak purity determination with principal component analysis of high-performance liquid chromatography-diode array detection data. J Chromatogr 2004;1029:13-20.